Which has stronger valuation & earnings, NAKA or ACTG?

Acacia Research has higher revenue and earnings than KindlyMD. Acacia Research is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 81.73 -$52.23M -$35.85 N/A Acacia Research $285.23M 1.54 $21.68M -$0.15 N/A

Does the media prefer FWDI or NAKA?

In the previous week, Forward Industries had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for Forward Industries and 2 mentions for KindlyMD. Forward Industries' average media sentiment score of 1.03 beat KindlyMD's score of 0.87 indicating that Forward Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forward Industries 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CEPO or NAKA?

KindlyMD has a consensus price target of $19.33, indicating a potential upside of 132.65%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts clearly believe KindlyMD is more favorable than Cantor Equity Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cantor Equity Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Does the media refer more to CEPO or NAKA?

In the previous week, KindlyMD had 1 more articles in the media than Cantor Equity Partners. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Cantor Equity Partners. Cantor Equity Partners' average media sentiment score of 1.95 beat KindlyMD's score of 0.87 indicating that Cantor Equity Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cantor Equity Partners 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NAKA or TROO?

KindlyMD presently has a consensus target price of $19.33, indicating a potential upside of 132.65%. Given KindlyMD's stronger consensus rating and higher probable upside, equities analysts clearly believe KindlyMD is more favorable than TROOPS. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 TROOPS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, NAKA or TROO?

TROOPS has higher revenue and earnings than KindlyMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 81.73 -$52.23M -$35.85 N/A TROOPS $17.10M 15.43 -$27.91M N/A N/A

Is NAKA or TROO more profitable?

TROOPS has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. TROOPS's return on equity of 0.00% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -1,067.93% -63.45% -41.04% TROOPS N/A N/A N/A

Does the media favor NAKA or TROO?

In the previous week, TROOPS had 12 more articles in the media than KindlyMD. MarketBeat recorded 14 mentions for TROOPS and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 0.87 beat TROOPS's score of -0.56 indicating that KindlyMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TROOPS 0 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Negative

Do analysts rate MAAS or NAKA?

KindlyMD has a consensus price target of $19.33, indicating a potential upside of 132.65%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Maase. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Maase 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better earnings and valuation, MAAS or NAKA?

Maase has higher revenue and earnings than KindlyMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Maase $109.05M 2.43 -$27.36M N/A N/A KindlyMD $1.82M 81.73 -$52.23M -$35.85 N/A

Is MAAS or NAKA more profitable?

Maase has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Maase's return on equity of 0.00% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets Maase N/A N/A N/A KindlyMD -1,067.93% -63.45% -41.04%

Does the media favor MAAS or NAKA?

In the previous week, KindlyMD had 1 more articles in the media than Maase. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Maase. KindlyMD's average media sentiment score of 0.87 beat Maase's score of 0.00 indicating that KindlyMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Maase 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

KindlyMD (NAKA) Competitors

$8.31 +0.63 (+8.20%)

As of 04:00 PM Eastern

Compare

NAKA vs. ACTG, FWDI, CEPO, TROO, and MAAS

Should you buy KindlyMD stock or one of its competitors? KindlyMD's main competitors and comparable companies include Acacia Research (ACTG), Forward Industries (FWDI), Cantor Equity Partners (CEPO), TROOPS (TROO), and Maase (MAAS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does KindlyMD compare to Acacia Research?

KindlyMD (NASDAQ:NAKA) and Acacia Research (NASDAQ:ACTG) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

KindlyMD currently has a consensus price target of $19.33, indicating a potential upside of 132.65%. Acacia Research has a consensus price target of $6.00, indicating a potential upside of 33.04%. Given KindlyMD's stronger consensus rating and higher possible upside, equities analysts clearly believe KindlyMD is more favorable than Acacia Research.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Acacia Research	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

KindlyMD has a beta of 15.99, indicating that its share price is 1,499% more volatile than the broader market. Comparatively, Acacia Research has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

Acacia Research has higher revenue and earnings than KindlyMD. Acacia Research is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	81.73	-$52.23M	-$35.85	N/A
Acacia Research	$285.23M	1.54	$21.68M	-$0.15	N/A

In the previous week, KindlyMD had 2 more articles in the media than Acacia Research. MarketBeat recorded 2 mentions for KindlyMD and 0 mentions for Acacia Research. KindlyMD's average media sentiment score of 0.87 beat Acacia Research's score of 0.00 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Positive
Acacia Research	Neutral

Acacia Research has a net margin of -5.39% compared to KindlyMD's net margin of -1,067.93%. Acacia Research's return on equity of 0.44% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Acacia Research	-5.39%	0.44%	0.33%

86.7% of Acacia Research shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by insiders. Comparatively, 1.7% of Acacia Research shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

KindlyMD beats Acacia Research on 9 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Forward Industries?

Forward Industries (NASDAQ:FWDI) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

KindlyMD has lower revenue, but higher earnings than Forward Industries. KindlyMD is trading at a lower price-to-earnings ratio than Forward Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forward Industries	$18.19M	27.12	-$166.97M	$0.12	55.67
KindlyMD	$1.82M	81.73	-$52.23M	-$35.85	N/A

Forward Industries has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.99, meaning that its stock price is 1,499% more volatile than the broader market.

In the previous week, Forward Industries had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for Forward Industries and 2 mentions for KindlyMD. Forward Industries' average media sentiment score of 1.03 beat KindlyMD's score of 0.87 indicating that Forward Industries is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Forward Industries	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

KindlyMD has a net margin of -1,067.93% compared to Forward Industries' net margin of -2,073.82%. Forward Industries' return on equity of -18.05% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Forward Industries	-2,073.82%	-18.05%	-17.03%
KindlyMD	-1,067.93%	-63.45%	-41.04%

Forward Industries currently has a consensus price target of $8.50, suggesting a potential upside of 27.25%. KindlyMD has a consensus price target of $19.33, suggesting a potential upside of 132.65%. Given KindlyMD's higher possible upside, analysts clearly believe KindlyMD is more favorable than Forward Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forward Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Forward Industries beats KindlyMD on 7 of the 12 factors compared between the two stocks.

How does KindlyMD compare to Cantor Equity Partners?

Cantor Equity Partners (NASDAQ:CEPO) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

KindlyMD has a consensus price target of $19.33, indicating a potential upside of 132.65%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts clearly believe KindlyMD is more favorable than Cantor Equity Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cantor Equity Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Cantor Equity Partners has a beta of -0.05, meaning that its stock price is 105% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.99, meaning that its stock price is 1,499% more volatile than the broader market.

In the previous week, KindlyMD had 1 more articles in the media than Cantor Equity Partners. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Cantor Equity Partners. Cantor Equity Partners' average media sentiment score of 1.95 beat KindlyMD's score of 0.87 indicating that Cantor Equity Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cantor Equity Partners	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cantor Equity Partners has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Cantor Equity Partners' return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cantor Equity Partners	N/A	N/A	-0.74%
KindlyMD	-1,067.93%	-63.45%	-41.04%

Cantor Equity Partners has higher earnings, but lower revenue than KindlyMD. Cantor Equity Partners is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cantor Equity Partners	N/A	N/A	-$6.66M	-$0.29	N/A
KindlyMD	$1.82M	81.73	-$52.23M	-$35.85	N/A

Summary

KindlyMD beats Cantor Equity Partners on 7 of the 13 factors compared between the two stocks.

How does KindlyMD compare to TROOPS?

KindlyMD (NASDAQ:NAKA) and TROOPS (NASDAQ:TROO) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

In the previous week, TROOPS had 12 more articles in the media than KindlyMD. MarketBeat recorded 14 mentions for TROOPS and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 0.87 beat TROOPS's score of -0.56 indicating that KindlyMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TROOPS	0 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Negative

KindlyMD has a beta of 15.99, suggesting that its stock price is 1,499% more volatile than the broader market. Comparatively, TROOPS has a beta of 3.55, suggesting that its stock price is 255% more volatile than the broader market.

TROOPS has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. TROOPS's return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
TROOPS	N/A	N/A	N/A

KindlyMD presently has a consensus target price of $19.33, indicating a potential upside of 132.65%. Given KindlyMD's stronger consensus rating and higher probable upside, equities analysts clearly believe KindlyMD is more favorable than TROOPS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
TROOPS	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

TROOPS has higher revenue and earnings than KindlyMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	81.73	-$52.23M	-$35.85	N/A
TROOPS	$17.10M	15.43	-$27.91M	N/A	N/A

Summary

KindlyMD and TROOPS tied by winning 6 of the 12 factors compared between the two stocks.

How does KindlyMD compare to Maase?

Maase (NASDAQ:MAAS) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Maase has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.99, suggesting that its stock price is 1,499% more volatile than the broader market.

Maase has higher revenue and earnings than KindlyMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maase	$109.05M	2.43	-$27.36M	N/A	N/A
KindlyMD	$1.82M	81.73	-$52.23M	-$35.85	N/A

In the previous week, KindlyMD had 1 more articles in the media than Maase. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Maase. KindlyMD's average media sentiment score of 0.87 beat Maase's score of 0.00 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Maase	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

KindlyMD has a consensus price target of $19.33, indicating a potential upside of 132.65%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Maase.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Maase	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Maase has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Maase's return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Maase	N/A	N/A	N/A
KindlyMD	-1,067.93%	-63.45%	-41.04%

Summary

KindlyMD beats Maase on 7 of the 12 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NAKA vs. The Competition

Export

Metric	KindlyMD	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$137.43M	$27.28B	$14.12B	$12.73B
Dividend Yield	N/A	6.06%	5.89%	8.86%
P/E Ratio	-0.23	19.84	26.10	25.38
Price / Sales	81.73	453.86	533.14	92.60
Price / Cash	N/A	152.05	38.37	52.26
Price / Book	0.63	3.18	2.13	6.14
Net Income	-$52.23M	$1.10B	$1.32B	$349.01M
7 Day Performance	7.50%	0.14%	0.13%	-1.47%
1 Month Performance	71.34%	12.87%	1.95%	2.47%
1 Year Performance	-95.08%	0.63%	12.28%	15.84%

KindlyMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NAKA KindlyMD	3.6069 of 5 stars	$8.31 +8.2%	$19.33 +132.7%	-95.9%	$137.43M	$1.82M	N/A	N/A	News Coverage Analyst Forecast Gap Up
ACTG Acacia Research	1.7723 of 5 stars	$4.49 -0.2%	$6.00 +33.6%	+39.0%	$438.18M	$285.23M	N/A	1,036
FWDI Forward Industries	2.4128 of 5 stars	$5.93 -2.0%	$7.50 +26.5%	N/A	$437.93M	$18.19M	49.42	100	News Coverage Analyst Forecast
CEPO Cantor Equity Partners	0.6627 of 5 stars	$10.76 -0.2%	N/A	+3.4%	$274.38M	N/A	N/A	2	Positive News Short Interest Increase High Trading Volume
TROO TROOPS	0.3323 of 5 stars	$1.98 +8.2%	N/A	+105.8%	$241.88M	$17.10M	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KindlyMD (NAKA) Competitors

NAKA vs. ACTG, FWDI, CEPO, TROO, and MAAS

How does KindlyMD compare to Acacia Research?

Summary

How does KindlyMD compare to Forward Industries?

Summary

How does KindlyMD compare to Cantor Equity Partners?

Summary

How does KindlyMD compare to TROOPS?

Summary

How does KindlyMD compare to Maase?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KindlyMD (NAKA) Competitors

NAKA vs. ACTG, FWDI, CEPO, TROO, and MAAS

How does KindlyMD compare to Acacia Research?

Do analysts prefer NAKA or ACTG?

Which has more volatility and risk, NAKA or ACTG?

Which has stronger valuation & earnings, NAKA or ACTG?

Does the media favor NAKA or ACTG?

Is NAKA or ACTG more profitable?

Do insiders and institutionals believe in NAKA or ACTG?

Summary

How does KindlyMD compare to Forward Industries?

Which has better earnings & valuation, FWDI or NAKA?

Which has more risk and volatility, FWDI or NAKA?

Does the media prefer FWDI or NAKA?

Is FWDI or NAKA more profitable?

Do analysts prefer FWDI or NAKA?

Summary

How does KindlyMD compare to Cantor Equity Partners?

Do analysts prefer CEPO or NAKA?

Which has more volatility and risk, CEPO or NAKA?

Does the media refer more to CEPO or NAKA?

Is CEPO or NAKA more profitable?

Which has higher valuation and earnings, CEPO or NAKA?

Summary

How does KindlyMD compare to TROOPS?

Does the media favor NAKA or TROO?

Which has more risk and volatility, NAKA or TROO?

Is NAKA or TROO more profitable?

Do analysts prefer NAKA or TROO?

Which has better valuation & earnings, NAKA or TROO?

Summary

How does KindlyMD compare to Maase?

Which has more risk & volatility, MAAS or NAKA?

Which has better earnings and valuation, MAAS or NAKA?

Does the media favor MAAS or NAKA?

Do analysts rate MAAS or NAKA?

Is MAAS or NAKA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools